1. Home
  2. KINS vs IMA Comparison

KINS vs IMA Comparison

Compare KINS & IMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KINS
  • IMA
  • Stock Information
  • Founded
  • KINS 1886
  • IMA 2019
  • Country
  • KINS United States
  • IMA United States
  • Employees
  • KINS N/A
  • IMA N/A
  • Industry
  • KINS Property-Casualty Insurers
  • IMA Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • KINS Finance
  • IMA Health Care
  • Exchange
  • KINS Nasdaq
  • IMA Nasdaq
  • Market Cap
  • KINS 189.6M
  • IMA 159.1M
  • IPO Year
  • KINS N/A
  • IMA N/A
  • Fundamental
  • Price
  • KINS $13.73
  • IMA $8.35
  • Analyst Decision
  • KINS
  • IMA
  • Analyst Count
  • KINS 0
  • IMA 0
  • Target Price
  • KINS N/A
  • IMA N/A
  • AVG Volume (30 Days)
  • KINS 149.6K
  • IMA 48.5K
  • Earning Date
  • KINS 10-28-2025
  • IMA 11-15-2025
  • Dividend Yield
  • KINS 1.46%
  • IMA N/A
  • EPS Growth
  • KINS 325.10
  • IMA N/A
  • EPS
  • KINS 2.04
  • IMA N/A
  • Revenue
  • KINS $183,702,376.00
  • IMA $4,300,000.00
  • Revenue This Year
  • KINS $41.35
  • IMA N/A
  • Revenue Next Year
  • KINS $12.33
  • IMA N/A
  • P/E Ratio
  • KINS $6.70
  • IMA N/A
  • Revenue Growth
  • KINS 28.36
  • IMA N/A
  • 52 Week Low
  • KINS $8.36
  • IMA $7.95
  • 52 Week High
  • KINS $22.40
  • IMA $23.28
  • Technical
  • Relative Strength Index (RSI)
  • KINS 46.67
  • IMA N/A
  • Support Level
  • KINS $13.38
  • IMA N/A
  • Resistance Level
  • KINS $13.92
  • IMA N/A
  • Average True Range (ATR)
  • KINS 0.47
  • IMA 0.00
  • MACD
  • KINS 0.08
  • IMA 0.00
  • Stochastic Oscillator
  • KINS 43.28
  • IMA 0.00

About KINS Kingstone Companies Inc.

Kingstone Companies Inc is a multi-line regional property and casualty insurance holding company. It offers insurance policies to small and mid-sized businesses as well as to individuals.

About IMA ImageneBio Inc. Common Stock

ImageneBio Inc is a clinical-stage biopharmaceutical company that develops differentiated therapies for immunological and inflammatory (I&I) diseases. The company is focused on developing IMG-007, a non-depleting anti-OX40 monoclonal antibody, for the treatment of atopic dermatitis.

Share on Social Networks: